Morningstar

Castle Biosciences Inc CSTL

Stock XNAS Rating as of Oct 2, 2026

News

Late-Breaking EADV 2026 Data Support Use of DecisionDx®-Melanoma in SLNB Decision-Making and Risk-Aligned Post Surgical Management

PR Newswire Sep 30, 2026, 8:30:00 PM
New Study Shows That TissueCypher® Changed Management at an Expert Surgery Center in 90% of Patients With Non-Dysplastic Barrett's Esophagus

PR Newswire Sep 28, 2026, 11:00:00 AM
New Study Highlights Clinical Need for Molecular Guidance in Atopic Dermatitis Treatment Selection, Reinforcing the Value of AdvanceAD-Tx™

PR Newswire Sep 24, 2026, 8:30:00 PM
Castle Biosciences to Open New Laboratory Facility in Scottsdale

PR Newswire Sep 22, 2026, 11:00:00 AM
New Decision Modeling Study Demonstrates TissueCypher® Significantly Improves Risk-Aligned Management for Patients with Barrett's Esophagus

PR Newswire Sep 15, 2026, 11:00:00 AM
JAAD Publication Shows Improved Performance of DecisionDx®-SCC

PR Newswire Sep 9, 2026, 8:30:00 PM
Castle Biosciences to Participate in Upcoming Investor Conferences

PR Newswire Aug 20, 2026, 11:00:00 AM
Castle Biosciences Approved for Dual Listing on Nasdaq Texas

PR Newswire Aug 17, 2026, 11:00:00 AM
Castle Biosciences Reports Second Quarter 2026 Results

PR Newswire Jul 30, 2026, 8:05:00 PM
Castle Biosciences to Present at the Canaccord Genuity 46th Annual Growth Conference

PR Newswire Jul 22, 2026, 11:00:00 AM
Castle Biosciences Announces New York State Department of Health Approval of its AdvanceAD-Tx™ Test

PR Newswire Jul 14, 2026, 8:30:00 PM
Castle Biosciences to Release Second Quarter 2026 Financial Results and Host Webcast on Thursday, July 30, 2026

PR Newswire Jul 9, 2026, 11:00:00 AM

Sponsor Center

Transparency is our policy. Learn how it impacts everything we do

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.

© Copyright 2026 Morningstar, Inc. All rights reserved. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.